End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma
Jeffrey A. BarnesCenter for Lymphoma, Massachusetts General Hospital Cancer Center; Department of Medicine, Harvard Medical SchoolAnn S. LaCasceDepartment of Medical Oncology, Dana-Farber Cancer Institute; Department of Medicine, Harvard Medical SchoolKatherine ZukotynskiDepartment of Imaging, Dana-Farber Cancer Institute; Department of Radiology, Harvard Medical SchoolDavid IsraelDepartment of Imaging, Dana-Farber Cancer Institute; Department of Radiology, Harvard Medical SchoolYang FengDepartment of Biostatistics, Dana-Farber Cancer InstituteDonna NeubergDepartment of Biostatistics, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health, Boston, USAChristiana E. ToomeyCenter for Lymphoma, Massachusetts General Hospital Cancer CenterEphraim P. HochbergCenter for Lymphoma, Massachusetts General Hospital Cancer Center; Department of Medicine, Harvard Medical SchoolGeorge P. CanellosDepartment of Medical Oncology, Dana-Farber Cancer Institute; Department of Medicine, Harvard Medical SchoolJeremy S. AbramsonCenter for Lymphoma, Massachusetts General Hospital Cancer Center; Department of Medicine, Harvard Medical School. Electronic address: [email protected]
2010en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0